Anti-CXCL5 抗体
Anti-CXCL5 antibody
5
(2 Reviews)
|
(11 Publications)
Rabbit Polyclonal CXCL5 antibody. Suitable for sELISA, WB and reacts with Recombinant fragment - Human, Recombinant full length protein - Human samples. Cited in 11 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human CXCL5.
別名を表示する
ENA78, SCYB5, CXCL5, C-X-C motif chemokine 5, ENA-78(1-78), Epithelial-derived neutrophil-activating protein 78, Neutrophil-activating peptide ENA-78, Small-inducible cytokine B5
- sELISA
Unknown
Sandwich ELISA - Anti-CXCL5 antibody (AB9802)
ab9802 detecting CXCL5 in sandwich ELISA
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
再構成
精製方法
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCL5 affects inflammation and the immune response by modulating neutrophil recruitment to sites of infection or injury. It is a part of the larger network of chemokines that direct leukocyte movement throughout the body. While CXCL5 does not form a complex in a traditional sense it does interact dynamically with CXCR2 receptor to exert its effects. These interactions are pivotal to the protein’s role in orchestrating the immune system’s response to diverse stimuli.
Pathways
CXCL5 plays a part in the chemokine signaling pathway and the inflammatory response pathway. These pathways are important in mediating immune surveillance and inflammation. CXCL5 through these pathways has a strong connection to other CXC family proteins like CXCL1 and the receptor CXCR2 which allows for a coordinated response during immune challenges and recovery processes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (11)
Recent publications for all applications. Explore the full list and refine your search
American journal of translational research 15:2676-2689 PubMed37193135
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:624 PubMed35853880
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biological research (Thessalonike, Greece) 28:7 PubMed33640021
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 20:497 PubMed33061849
2020
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 15:e0228015 PubMed31999765
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 23:8161-8172 PubMed31565850
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 35:868-884.e6 PubMed31185211
2019
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 53:2433-2444 PubMed30272278
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 32:4436-47 PubMed23045282
2012
Applications
IP
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 108:2444-9 PubMed21248225
2011
Applications
IP
Species
Human
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com